Jeroen Vanderhoeven
- Virology top 2%
- Infectious Diseases top 5%
- Epidemiology
- Public Health, Environmental and Occupational Health top 10%
- Pediatrics, Perinatology and Child Health top 10%
- Co-authors
- Viviana SimonMartin MarkowitzBharat RamratnamArlene HurleySophia LannonKristina M. Adams WaldorfMichael J. LouieMichael G. Gravett
- Topics
- HIV Research and Treatment (5 papers)HIV/AIDS Research and Interventions (5 papers)HIV/AIDS drug development and treatment (5 papers)
- Partner nations
- United StatesSwitzerlandArgentina
In The Last Decade
Jeroen Vanderhoeven
17 papers receiving 710 citations
Peers
Comparison fields: 5 of 69
- Virology 376
- Infectious Diseases 341
- Epidemiology 183
- Public Health, Environmental and Occupational Health 147
- Pediatrics, Perinatology and Child Health 145
Countries citing papers authored by Jeroen Vanderhoeven
This map shows the geographic impact of Jeroen Vanderhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeroen Vanderhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeroen Vanderhoeven more than expected).
Fields of papers citing papers by Jeroen Vanderhoeven
This network shows the impact of papers produced by Jeroen Vanderhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeroen Vanderhoeven. The network helps show where Jeroen Vanderhoeven may publish in the future.
Co-authorship network of co-authors of Jeroen Vanderhoeven
This figure shows the co-authorship network connecting the top 25 collaborators of Jeroen Vanderhoeven. A scholar is included among the top collaborators of Jeroen Vanderhoeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeroen Vanderhoeven. Jeroen Vanderhoeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 58 | |
| 5 | 45 | |
| 6 | 24 | |
| 7 | 50 | |
| 8 | 4 | |
| 9 | 62 | |
| 10 | 48 | |
| 11 | 1 | |
| 12 | 25 | |
| 13 | 98 | |
| 14 | 35 | |
| 15 | 106 | |
| 16 | 112 | |
| 17 | 54 |
About Jeroen Vanderhoeven
Jeroen Vanderhoeven is a scholar working on Virology, Obstetrics and Gynecology and Infectious Diseases, having authored 17 papers that have together received 738 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Virology (376 citations), Infectious Diseases (341 citations) and Obstetrics and Gynecology (131 citations). Jeroen Vanderhoeven has collaborated with scholars based in United States, Switzerland and Argentina. Frequent co-authors include Viviana Simon, Martin Markowitz, Bharat Ramratnam, Arlene Hurley, Sophia Lannon, Kristina M. Adams Waldorf, Michael J. Louie, Michael G. Gravett, Chris Chung and David D. Ho. Their work appears in journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.